News & Updates
Filter by Specialty:
Show Multimedia Only

Novel RSV vaccine safe to use in solid organ transplant recipients
17 Nov 2025
byStephen Padilla
Two doses of mRNA-1345 respiratory syncytial virus (RSV) vaccine 50 µg administered 56 days apart do not yield any safety concerns and are well-tolerated among solid organ transplant recipients (SOTRs), according to a study presented at IDWeek 2025.








